MedPath

Effect of Ozone Gel on Treatment of Chronic Periodontitis

Phase 2
Completed
Conditions
Periodontal Diseases
Interventions
Procedure: scaling and root planing
Drug: placebo gel
Registration Number
NCT02066337
Lead Sponsor
October 6 University
Brief Summary

To evaluate the efficacy of locally delivered ozone gel as an adjunct to conventional periodontal therapy on selected clinical parameters as well as alveolar bone density (BD) and superoxide dismutase (SOD) activity in patient with chronic periodontitis.

Detailed Description

In this study, the investigators tested the effect of ozone gel as a local delivery system in treatment of chronic periodontitis in term of probing pocket depth reduction, mean gain in clinical attachment level, a more rise in BD values as well as greater reduction in SOD activity compared to scaling and root planing (SRP) alone.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. The participant's age ranged between 30 and 60 years.
  2. All of the patients suffered from chronic periodontitis with attachment loss ≥ 5mm.
  3. Willingness to participate and sign the informed consent.
Exclusion Criteria
  1. Any systemic disease that affect the periodontium.
  2. Pregnancy, lactation, postmenopausal women
  3. People who take anti-inflammatory drugs, antibiotics or vitamins within the previous 3 month.
  4. People who use mouth washes regularly
  5. Heavy smoking (> 10 cigarettes/day)
  6. History of alcohol abuse.
  7. Participation in other clinical trials.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ozonated olive oil gelscaling and root planingscaling and root planing with Ozonated olive oil gel
placebo gelscaling and root planingscaling and root planing with placebo gel
Ozonated olive oil gelOzonated olive oil gelscaling and root planing with Ozonated olive oil gel
placebo gelplacebo gelscaling and root planing with placebo gel
Primary Outcome Measures
NameTimeMethod
Superoxide dismutase activity6 months

Superoxide dismutase activity in the gingival crevicular fluid was carried out at baseline, 1, 3 and 6 months post treatment.

Secondary Outcome Measures
NameTimeMethod
Gingival index6 months

Gingival index was recorded at base line,1,3,6 months post treatment

Probing pocket depth6 months

Probing pocket depth was recorded at base line, 1, 3, 6 months post treatment

Plaque Index6 months

plaque index was recorded at baseline and at 1, 3 and 6 months post treatment.

Bone density6 months

Bone density was carried out using Digora software (Digora system, Soredex, Orion Corp., Finland) at baseline and 6 months

Clinical attachment level6 months

Clinical attachment level was recorded at baseline, 1, 3 and 6 months post treatment

Trial Locations

Locations (1)

October 6 University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath